Summary

Dr. Eric Topol – Founder and Director, Scripps Research Translational Institute: A prolific writer and speaker, Dr. Topol is a prominent advocate for personalized medicine, emphasizing the role of genomics and digital health tools in individualized care. Dr. Francis Collins – Dir…

Key Takeaway

• Eric Topol – Founder and Director, Scripps Research Translational Institute: A prolific writer and speaker, Dr.
• Topol is a prominent advocate for personalized medicine, emphasizing the role of genomics and digital health tools in individualized care.
• Francis Collins – Director, National Institutes of Health (NIH): Having led the Human Genome Project, Dr.
• Collins is a stalwart in the realm of genomics and its implications for personalized medical treatments.
• Anne Wojcicki – Co-founder and CEO, 23andMe: Through 23andMe, Wojcicki has championed direct-to-consumer genetic testing, providing insights into genetics and promoting a personalized approach to health.

Body

Dr. Eric Topol – Founder and Director, Scripps Research Translational Institute: A prolific writer and speaker, Dr. Topol is a prominent advocate for personalized medicine, emphasizing the role of genomics and digital health tools in individualized care. Dr. Francis Collins – Director, National Institutes of Health (NIH): Having led the Human Genome Project, Dr. Collins is a stalwart in the realm of genomics and its implications for personalized medical treatments. Dr. Anne Wojcicki – Co-founder and CEO, 23andMe: Through 23andMe, Wojcicki has championed direct-to-consumer genetic testing, providing insights into genetics and promoting a personalized approach to health. Dr. Craig Venter – Biotechnologist, Genomic Researcher: Renowned for his role in sequencing the human genome, Dr. Venter continues to explore the genomic frontier, emphasizing its role in tailoring medical interventions. Dr. Leroy Hood – Chief Science Officer, Providence St. Joseph Health; Co-founder, Institute for Systems Biology: Dr. Hood’s pioneering work in systems biology and the invention of automated DNA sequencing has set the stage for personalized medicine’s advancements. Dr. Jennifer Doudna – Biochemist, University of California, Berkeley: As a key figure in the development of CRISPR gene-editing technology, Dr. Doudna’s work is poised to revolutionize personalized therapeutic interventions. Dr. George Church – Professor, Harvard Medical School: Renowned for his work in genetics, synthetic biology, and genome sequencing, Dr. Church is at the forefront of exploring genomic applications in personalized therapies. Dr. Atul Butte – Director, Institute for Computational Health Sciences, UCSF: Dr. Butte focuses on transforming trillions of data points into diagnostics, therapeutics, and new insights into personalized disease prevention. Dr. Kathy Giusti – Founder and Chief Mission Officer, Multiple Myeloma Research Foundation: Drawing from her own experience with multiple myeloma, Giusti’s foundation accelerates personalized treatment approaches for patients. Dr. Patrick Soon-Shiong – Surgeon, Entrepreneur, Philanthropist: Dr. Soon-Shiong’s work in developing novel therapies for diabetes and cancer has made him a standout figure in the push for personalized medicine.

Final Takeaway

Decide what matters, execute in short cycles, and make progress visible every week—so you enter 2026 with momentum.

About Ian Khan – Keynote Speaker & The Futurist

Ian Khan, the Futurist, is a USA Today & Publishers Weekly National Bestselling Author of Undisrupted, Thinkers50 Future Readiness shortlist, and a Top Keynote Speaker. He is Futurist and a media personality focused on future-ready leadership, AI productivity and ethics, and purpose-driven growth. Ian hosts The Futurist on Amazon Prime Video, and founded Impact Story (K-12 Robotics & AI). He is frequently featured on CNN, BBC, Bloomberg, and Fast Company.

Mini FAQ: About Ian Khan